Literature DB >> 15574612

Trends in risk factors for cardiovascular disease among children and adolescents in the United States.

Earl S Ford1, Ali H Mokdad, Umed A Ajani.   

Abstract

BACKGROUND: The increasing prevalence of obesity among children and adolescents in recent decades might have affected trends in obesity-associated risk factors for cardiovascular disease. PARTICIPANTS AND METHODS: We used data for 12,665 children and adolescents, 2 to 17 years of age, from the Third National Health and Nutrition Examination Survey (1988-1994) and for 3611 children and adolescents from National Health and Nutrition Examination Survey 1999-2000.
RESULTS: For participants 2 to 17 years of age, waist circumference increased 1.6 cm among male subjects and 2.4 cm among female subjects. Mean systolic blood pressure increased by 2.2 mm Hg among children and adolescents 8 to 17 years of age. There were significant decreases in concentrations of triglycerides (8.8 mg/dL) and glucose (2.5 mg/dL) among children and adolescents 12 to 17 years of age. Mean concentrations of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and glycosylated hemoglobin were relatively unchanged. Some changes in means of risk factors varied according to age.
CONCLUSIONS: The temporal trends for risk factors among children and adolescents during the 1990s exhibited different patterns. The effects of the increasing prevalence of obesity on the cardiovascular health of children and adolescents remain unclear.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574612     DOI: 10.1542/peds.2004-0674

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

Review 1.  Addressing childhood overweight and obesity in the dental office: rationale and practical guidelines.

Authors:  Ray Tseng; William F Vann; Eliana M Perrin
Journal:  Pediatr Dent       Date:  2010 Sep-Oct       Impact factor: 1.874

2.  Presence of diabetes risk factors in a large U.S. eighth-grade cohort.

Authors:  T Baranowski; D M Cooper; J Harrell; K Hirst; F R Kaufman; M Goran; K Resnicow
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

Review 3.  Cholesterol screening and statin use in children: a literature review.

Authors:  Karen King; Alan Macken; Ophelia Blake; Clodagh S O'Gorman
Journal:  Ir J Med Sci       Date:  2018-06-01       Impact factor: 1.568

4.  Changes in metabolic syndrome of Korean children and adolescents in the period 1998 to 2001.

Authors:  S Lim; H C Jang; K S Park; H K Lee; H R Chung; H J Joung; S I Cho
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

5.  Valsartan: in children and adolescents with hypertension.

Authors:  Jamie D Croxtall
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

6.  Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality.

Authors:  Sharon Saydah; Kai McKeever Bullard; Giuseppina Imperatore; Linda Geiss; Edward W Gregg
Journal:  Pediatrics       Date:  2013-02-18       Impact factor: 7.124

Review 7.  Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter.

Authors:  Holly C Gooding; Sarah D de Ferranti
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

8.  Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study.

Authors:  David C Kaelber; Weiwei Liu; Michelle Ross; A Russell Localio; Janeen B Leon; Wilson D Pace; Richard C Wasserman; Alexander G Fiks
Journal:  Pediatrics       Date:  2016-12       Impact factor: 7.124

9.  Medical management of children with primary hypertension by pediatric subspecialists.

Authors:  Esther Y Yoon; Matthew M Davis; Albert Rocchini; David Kershaw; Gary L Freed
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

10.  Risks for hypertension among undiagnosed African American mothers and daughters.

Authors:  Jacquelyn Y Taylor
Journal:  J Pediatr Health Care       Date:  2008-10-23       Impact factor: 1.812

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.